Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5230 | 1585 | 38.0 | 86% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AMINOETHYL ISOTHIOUREA | Author keyword | 9 | 83% | 0% | 5 |
2 | VASCULAR HYPOREACTIVITY | Author keyword | 6 | 35% | 1% | 13 |
3 | N G METHYL L ARGININE HYDROCHLORIDE | Author keyword | 6 | 100% | 0% | 4 |
4 | ENDOTOXIC SHOCK | Author keyword | 4 | 12% | 2% | 34 |
5 | INTEGRAT PHYSIOL CLIN SCI | Address | 4 | 31% | 1% | 10 |
6 | MED SCI INTEGRAT PHYSIOL CLIN SCI | Address | 3 | 100% | 0% | 3 |
7 | VASCULAR HYPORESPONSIVENESS | Author keyword | 3 | 50% | 0% | 4 |
8 | VASCULAR ENDOTHELIAL CELL FUNCTION | Author keyword | 3 | 60% | 0% | 3 |
9 | CLIN NUTR SUPPORT SERV TEAM | Address | 2 | 67% | 0% | 2 |
10 | INTENSE CARE MED | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | L ARGININE PATHWAY | 43 | 56% | 3% | 53 |
2 | METHYL L ARGININE | 30 | 31% | 5% | 80 |
3 | ENDOTOXIN SHOCK | 16 | 17% | 6% | 90 |
4 | ESCHERICHIA COLI ENDOTOXEMIA | 13 | 45% | 1% | 22 |
5 | ENDOTOXIN INDUCED IMPAIRMENT | 13 | 80% | 1% | 8 |
6 | GLUCOCORTICOIDS INHIBIT | 11 | 19% | 3% | 49 |
7 | ENDOTOXIC SHOCK | 10 | 11% | 5% | 85 |
8 | PROTECTIVE ACTIONS | 9 | 67% | 1% | 8 |
9 | CEREBRAL COMPRESSION | 8 | 70% | 0% | 7 |
10 | VASCULAR HYPOREACTIVITY | 7 | 31% | 1% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nitric oxide in shock | 2007 | 69 | 117 | 45% |
Nitric oxide and septic shock | 1997 | 220 | 44 | 55% |
The role of nitric oxide in sepsis - an overview | 1999 | 158 | 120 | 43% |
Is nitric oxide overproduction the target of choice for the management of septic shock? | 2001 | 94 | 399 | 48% |
Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies | 1997 | 116 | 83 | 70% |
Nitrite regulation of shock | 2011 | 22 | 82 | 29% |
Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside | 2010 | 47 | 77 | 25% |
Methylene Blue for the Treatment of Septic Shock | 2010 | 19 | 51 | 49% |
Sepsis: An arginine deficiency state? | 2004 | 91 | 164 | 39% |
Nitric oxide in septic shock | 1999 | 266 | 101 | 19% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTEGRAT PHYSIOL CLIN SCI | 4 | 31% | 0.6% | 10 |
2 | MED SCI INTEGRAT PHYSIOL CLIN SCI | 3 | 100% | 0.2% | 3 |
3 | CLIN NUTR SUPPORT SERV TEAM | 2 | 67% | 0.1% | 2 |
4 | INTENSE CARE MED | 2 | 67% | 0.1% | 2 |
5 | PHARMACOL PHYSIOL CELLULAI | 2 | 50% | 0.2% | 3 |
6 | AC BURTON VASC BIOL | 2 | 21% | 0.5% | 8 |
7 | SHIN KONG WU HO SU MEM HOSP | 1 | 21% | 0.4% | 6 |
8 | BLOOD SUBSTITUTES COMPONENTS | 1 | 100% | 0.1% | 2 |
9 | ERS 653 | 1 | 100% | 0.1% | 2 |
10 | FU JEN CATHOLIC MED | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000164030 | SEPTIC CARDIOMYOPATHY//CARDIONOME//MYOCARDIAL DEPRESSION |
2 | 0.0000131796 | MOL INNOVAT DRUG DISCOVERY//N HYDROXYGUANIDINES//LERNER FDN |
3 | 0.0000130078 | CYTOPATHIC HYPOXIA//BLOOMSBURY INTENS CARE MED//ABT KLIN PATHOPHYSIOL EXPT MED |
4 | 0.0000098659 | VASODILATORY SHOCK//VASOPLEGIC SYNDROME//VASOPLEGIA |
5 | 0.0000098221 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
6 | 0.0000092986 | EDRF//NG NITRO L ARGININE//EDRF ENDOTHELIUM DERIVED RELAXING FACTOR |
7 | 0.0000075373 | ARTIF ORGANS TRANSPLANTAT GENE THER Y//CHEM TECH INC//CHRONIC RENAL TRANSPLANT FAILURE |
8 | 0.0000074591 | MESENTERIC LYMPH//MESENTERIC LYMPH DUCT//2STATE TRAUMA BURNS COMBINED INJU |
9 | 0.0000074429 | TYPE I INTERLEUKIN 1 RECEPTOR//INOS PROMOTER//ORG SCI TECHNOL |
10 | 0.0000072737 | SIDESTREAM DARK FIELD IMAGING//ORTHOGONAL POLARIZATION SPECTRAL IMAGING//SDF IMAGING |